New Zealand will be a nice boost. Will it be covered via national health insurance? How many in the initial order? Nonetheless it is a welcome addition. Another inch towards the final goal, whatever that may be. Taiwan is coming along nicely it seems. Getting accepted into the world’s best rated health care system says a lot about the product and us, as a company. And again, having it covered via their national health insurance is the goal but selling product is always a good thing. And one good thing leads to another.
We have been accepted into the product offerings of Med-Vet International, a vet/pet supplier w/ a client list of 150,000 and it does not merit a press release. PRs cost money, I get it. I can only conclude the ‘deal’ to which CEO Kelly has hinted at is not this; ditto for NZ and Taiwan. Ok, so what is it? It seems to me the engine of BIEL is revving up and we don’t know what is under the hood.
The pieces of the puzzle are Viant, Haleon, CMMS, Insurance, and the VA; as I see it. Please feel free to to add to, or amend, the list. I think the probability of us having a manufacturing relationship w/ Viant, of one sort or another, is very high. Same w/ the Veterans Administration.
Potentially, the VA is a political gold mine for the Trump administration should he choose to go that route. By this I mean, he could get Actipatch/RecoveryRx accepted nationwide (w/ coverage) in a big splash about reducing opioid abuse for our veterans and saving the country millions of $$ in the process. Would fit in nicely w/ this whole DOGE thing. It would make Headline News and rocket the share price.
CEO Kelly made a point of ‘liking’ Haleon. For what reason I am compelled to ask. CMMS is a black hole; anyone’s guess. Overall, information is infrequent, vague and indeterminate. Trying to catch smoke in your hands and reading tea leaves simultaneously. Announcing initial orders for Taiwan and NZ will certainly move the share price needle. A VA announcement w/ coverage would supercharge it, no doubt about that. But is it the secret the CEO is protecting like a formula to turn flax into gold?
Which leaves Haleon and Insurance coverage. It might be getting listed as a product in the Haleon catalog for 150 countries. Would definitely need Viant for that. Haleon could buy us out easily for $0.10 per share. I would gladly ride off into the sunset w/ that. Whatever happens vis-a-vis Haleon is secondary to getting on the Health Insurance schedule of coverage. Getting on that schedule of coverage is the holy grail. Haleon, the brainchild of GSK and Pfizer, two of the biggest hitters in the big pharma world, would certainly be privy to anything along those lines. Fingers crossed.
All the best, WBeacham
We have been accepted into the product offerings of Med-Vet International, a vet/pet supplier w/ a client list of 150,000 and it does not merit a press release. PRs cost money, I get it. I can only conclude the ‘deal’ to which CEO Kelly has hinted at is not this; ditto for NZ and Taiwan. Ok, so what is it? It seems to me the engine of BIEL is revving up and we don’t know what is under the hood.
The pieces of the puzzle are Viant, Haleon, CMMS, Insurance, and the VA; as I see it. Please feel free to to add to, or amend, the list. I think the probability of us having a manufacturing relationship w/ Viant, of one sort or another, is very high. Same w/ the Veterans Administration.
Potentially, the VA is a political gold mine for the Trump administration should he choose to go that route. By this I mean, he could get Actipatch/RecoveryRx accepted nationwide (w/ coverage) in a big splash about reducing opioid abuse for our veterans and saving the country millions of $$ in the process. Would fit in nicely w/ this whole DOGE thing. It would make Headline News and rocket the share price.
CEO Kelly made a point of ‘liking’ Haleon. For what reason I am compelled to ask. CMMS is a black hole; anyone’s guess. Overall, information is infrequent, vague and indeterminate. Trying to catch smoke in your hands and reading tea leaves simultaneously. Announcing initial orders for Taiwan and NZ will certainly move the share price needle. A VA announcement w/ coverage would supercharge it, no doubt about that. But is it the secret the CEO is protecting like a formula to turn flax into gold?
Which leaves Haleon and Insurance coverage. It might be getting listed as a product in the Haleon catalog for 150 countries. Would definitely need Viant for that. Haleon could buy us out easily for $0.10 per share. I would gladly ride off into the sunset w/ that. Whatever happens vis-a-vis Haleon is secondary to getting on the Health Insurance schedule of coverage. Getting on that schedule of coverage is the holy grail. Haleon, the brainchild of GSK and Pfizer, two of the biggest hitters in the big pharma world, would certainly be privy to anything along those lines. Fingers crossed.
"Sic parvis magma" - Greatness from small beginningsQuote:THESE are the times that try men’s souls. The summer soldier and the sunshine patriot will, in this crisis, shrink from the service of their country; but he that stands it now, deserves the love and thanks of man and woman.
All the best, WBeacham
1
